Product Safety Recalls

Product Recall Tracker

LANSOPRAZOLE Recall D-0853-2022

Description: Lansoprazole Delayed-Release Orally Disintegrating Tablets, 30 mg, 10 Packs of 10 Tablets each, 100 Tablets per blister pack, Rx Only, Distributed by: Dr. Reddy's Laboratories, Inc., Princeton, NJ 08540, Made in India, NDC 43598-561-78.

LANSOPRAZOLE Recall D-0853-2022 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-0853-2022
Event ID90021
BrandLANSOPRAZOLE
Generic NameLANSOPRAZOLE
ManufacturerLANSOPRAZOLE
Original Package?1
Active SubstanceLANSOPRAZOLE
Drug RouteORAL
DistributionOH
Quantity252 Blister Packs
Recall ReasonFailed Dissolution Specifications
Drug ClassificationClass II
Drug Code Info20220511
Product NDC43598-560 43598-561
Product NUIN0000175525 N0000000147 N0000009724
Pharma Class (PE)Inhibition Gastric Acid Secretion [PE]
Pharma Class (EPC)Proton Pump Inhibitor [EPC]
Recall Initiation Date20220415
Report Date20220511
Classification Date20220505
Address107 College Rd E
Princeton, NJ 08540-6623
United States
Recalling FirmDr. Reddy's Laboratories, Inc.
Initial Notification Letter
Unique Ingredient Identifier0K5C5T2QPG
Drug Application NumberANDA210465
Structured Product Labeling (SPL ID)d07a82ca-89b1-abd0-efa4-5319fbe805c3
Structured Product Labeling (SPL Set ID)656bc92a-1f95-047d-cd27-724073e63fe6
Similar To

© 2021 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.